Last reviewed · How we verify
Glycyron — Competitive Intelligence Brief
marketed
glycyrrhizic acid
High mobility group protein B1, Corticosteroid 11-beta-dehydrogenase isozyme 2, Corticosteroid 11-beta-dehydrogenase isozyme 1
Metabolic
Live · refreshed every 30 min
Target snapshot
Glycyron (glycyrrhizic acid).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Glycyron TARGET | glycyrrhizic acid | marketed | glycyrrhizic acid | High mobility group protein B1, Corticosteroid 11-beta-dehydrogenase isozyme 2, Corticosteroid 11-beta-dehydrogenase isozyme 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (glycyrrhizic acid class)
- · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Glycyron CI watch — RSS
- Glycyron CI watch — Atom
- Glycyron CI watch — JSON
- Glycyron alone — RSS
- Whole glycyrrhizic acid class — RSS
Cite this brief
Drug Landscape (2026). Glycyron — Competitive Intelligence Brief. https://druglandscape.com/ci/glycyrrhizic-acid. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab